41/94US=23 / Câncer
Kelly CMA, Ryan DN, Penny SA, Gallagher WM. Systematic validation of breast cancer biomarkers using tissue microarrays: from construction to image analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 235-50. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TISSUE MICROARRAYS (TMA); VALIDACAO SISTEMATICA DE BIOMARCADORES; CONSTRUCAO DA IMAGEM; ANALISE DE IMAGEM; PELLET CELULAR; IMUNOHISTOQUIMICA

42/94US=23 / Câncer
Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS

43/94US=23 / Câncer
Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA

44/94US=23 / Câncer
Tot T. Metaplastic breast carcinoma: detection using histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 275-90. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA DE MAMA METAPLASICO; HISTOLOGIA; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS; PROGNOSTICO

45/94US=23 / Câncer
van Diest PJ, Moelans CB, Purnomosari D, Pals G, de Weger RA. Invasive breast cancer: overexpression of HER-2 determined by immunohistochemistry and multiplex ligation-dependent probe amplification. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 291-304. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA INVASIVO; SUPEREXPRESSAO DE HER-2; IMUNOHISTOQUIMICA; LIGADURA MULTIPLEX DEPENDENTE

46/94US=23 / Câncer
Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE

47/94US=23 / Câncer
Peiró G. Lymph node-negative breast carcinoma: assessment of HER-2/neu gene status as prognostic value. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 569-81. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; LINFONODO NEGATIVO; CARCINOMA DE MAMA; AVALIACAO DA HER-2/NEU; STATUS GENETICO; VALOR PROGNOSTICO; SUPEREXPRESSAO DA PROTEINA; ELISA; IMUNOHISTOQUIMICA; MRNA; AMPLIFICACAO DO GENE

48/94US=23-A / Câncer
Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR

49/94US=23-A / Câncer
Zander DS, Clarke LE. Differentiation between pleuropulmonary desmoid tumors and solitary fibrous tumors: role of histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 363-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; TUMORES PLEUROPULMONARES DESMOIDE; TUMORES FIBROSOS SOLITARIOS; HISTOLOGIA; IMUNOHISTOQUIMICA; PATOLOGIA MACROSCOPICA; PATOLOGIA MICROSCOPICA

50/94US=23-B / Câncer
Tomita Y, Uyama H, Nakamura H. Pancreatic cancer: hepatoma-derived growth factor as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 183-9. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; HEPATOMA; FATOR DE CRESCIMENTO DERIVADO; FATOR PROGNOSTICO; IMUNOHISTOQUIMICA

51/94US=23-C / Câncer
Shinji S, Naito Z, Ishiwata T, Matsuda Y, Seya T, Tajiri T. Poorly differentiated colorectal adenocarcinoma (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 13-23. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; ADENOCARCINOMA COLORRETAL POUCO DIFERENCIADO; HISTOPATOLOGIA; IMUNOHISTOQUIMICA; HIBRIDIZACAO IN SITU

52/94US=23-C / Câncer
Alnabulsi A, Carpenter B, Telfer C, Murray GI. Colorectal cancer: immunohistochemical diagnosis with heterogeneous nuclear ribonucleoprotein K. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 25-42. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; RIBONUCLEOPROTEINA K; BIOMARCADORES

53/94US=23-C / Câncer
Atkin GK, Wilson GD. Rectal cancer: spectral imaging and immunohistochemistry of thymidylate synthase. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 329-39. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; CANCER DE RETAL; CANCER DE RETO; DIAGNOSTICO; IMAGEM ESPECTRAL; IMUNOHISTOQUIMICA; TIMIDILATO SINTASE

54/94US=23-C / Câncer
Owens SR. Anal squamous cell carcinomas: diagnosis using p63 immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 463-70. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; CANCER DE ANUS; CARCINOMAS ESCAMOSOS DE CELULAS ANAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; P63

55/94US=38 / Biol/Mol
Proytcheva MA. Leukemia and lymphoma immunophenotyping and cytogenetics. In: O'Gorman MRG, Donnenbeg AD. Handbook of human immunology. 2ª ed. Boca Raton: CRC, 2008. p. 221-56. ISBN 978-0-8493-1984-6.

LEUCEMIA; LINFOMA IMUNOFENOTIPAGEM; CITOGENETICA; IMUNOFENOTIPAGEM; ANTICORPOS; IMUNOHISTOQUIMICA; IMUNOFENOTIPAGEM DE LEUCEMIA; LINFOMA

56/94US=4 / Gastro
Harnden P. Pathology of adult renal parenchymal cancers. In: Patel U. Carcinoma of the kidney. New York: Cambridge University Press, 2008. p. 17-37. (Contemporary Issues in Cancer Imaging) ISBN 978-0-521-87838-8.

CANCER DE RIM. PATOLOGIA; PARENQUIMA RENAL; CANCER DE RIM. CLASSIFICACAO; CANCER DE RIM. DIAGNOSTICO; ADENOMA RENAL; CARCINOMA; ONCOCITOMA; IMUNOHISTOQUIMICA; FATORES PROGNOSTICOS; BIOPSIA

57/94US=56 / Biol/Mol
Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 13-21. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

CASPASE-3; APOPTOSE; ESTRESSE GENOTOXICO; IRRADIACAO; PARP-1; CITOMETRIA DE FLUXO; IMUNOHISTOQUIMICA

58/94US=90 / Biol/Mol
Eberhard DA. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR mutations, other molecular alterations related to sensitivity to EGFR-targeted therapies in non-small cell lung cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 293-336. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DE QUINASE DE TIROSINA; DIAGNOSTICOS MOLECULARES; MUTACOES; HIBRIDACAO IN SITU FLUORESCENTE; IMUNOHISTOQUIMICA; CANCER DE PULMAO

59/94US=47 / Biol/Mol
Hunt J, Davydova L, Cartun RW, Baiulescu M. Immunohistochemistry. In: Coleman WB, Tsongalis GJ. Molecular diagnostics: for the clinical laboratorian. 2ª ed. Totowa: Humana Press, 2006. p. 203-17. ISBN 1-58829-356-4.

DIAGNOSTICO MOLECULAR; IMUNOHISTOQUIMICA; ANTICORPOS; TECNICAS IMUNOHISTOQUIMICAS; DIAGNOSTICO TUMORAL

60/94US=16 / Tórax
Miller YE, Petty TL, Lam S. Screening/early detection/prevention: the early detection of lung cancer using bronchoscopy and cytologic analysis. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 189-99. ISBN 0-7817-4620-5.

NEOPLASIA PULMONAR; BRONCOSCOPIA; ANALISE CITOLOGICA; TABAGISMO; FATOR DE RISCO; CARCINOGENESE; DETECCAO; PREVENCAO; IMUNOHISTOQUIMICA; ANALISE MOLECULAR

Primeira | Anterior | Próxima | Última